Nutritional status assessment in patients with Covid-19 after discharge from the intensive care unit.

Department of Endocrinology and Metabolic Diseases, CHU Ibn Rochd, Casablanca, Morocco; Faculty of Medicine and Pharmacy, University Hassan II, Casablanca, Morocco. Department of Endocrinology and Metabolic Diseases, CHU Ibn Rochd, Casablanca, Morocco; Faculty of Medicine and Pharmacy, University Hassan II, Casablanca, Morocco. Electronic address: drachadli@gmail.com. Surgical Intensive Care and Anaesthesia Department, CHU Ibn Rochd, Casablanca, Morocco; Faculty of Medicine and Pharmacy, University Hassan II, Casablanca, Morocco. Surgical Emergencies Intensive Care and Anaesthesia Department, CHU Ibn Rochd, Casablanca, Morocco; Faculty of Medicine and Pharmacy, University Hassan II, Casablanca, Morocco. Medical Intensive Care Department, CHU Ibn Rochd, Casablanca, Morocco; Faculty of Medicine and Pharmacy, University Hassan II, Casablanca, Morocco. Laboratory of Parasitology, CHU Ibn Rochd, Casablanca, Morocco; Faculty of Medicine and Pharmacy, University Hassan II, Casablanca, Morocco. Department of Psychiatry, CHU Ibn Rochd, Casablanca, Morocco; Faculty of Medicine and Pharmacy, University Hassan II, Casablanca, Morocco. Laboratory of Biochemistry, CHU Ibn Rochd, Casablanca, Morocco; Faculty of Medicine and Pharmacy, University Hassan II, Casablanca, Morocco. Cardiology Department, CHU Ibn Rochd, Casablanca, Morocco; Faculty of Medicine and Pharmacy, University Hassan II, Casablanca, Morocco. Department of Infectious Diseases, CHU Ibn Rochd, Casablanca, Morocco; Faculty of Medicine and Pharmacy, University Hassan II, Casablanca, Morocco. Department of Nephrology, CHU Ibn Rochd, Casablanca, Morocco; Faculty of Medicine and Pharmacy, University Hassan II, Casablanca, Morocco. Microbiology Laboratory, CHU Ibn Rochd, Casablanca, Morocco; Faculty of Medicine and Pharmacy, University Hassan II, Casablanca, Morocco. Pneumology Department, 20 Août Hospital, CHU Ibn Rochd, Casablanca, Morocco; Faculty of Medicine and Pharmacy, University Hassan II, Casablanca, Morocco.

Clinical nutrition ESPEN. 2021;:423-428

Abstract

INTRODUCTION The nutritional diagnosis and early nutritional management of COVID-19 patients must be integrated into the overall therapeutic strategy. The aim of our study is to assess the nutritional status of patients with COVID-19 after a stay in intensive care, to describe the prevalence of undernutrition, to determine the factors influencing undernutrition and to describe the nutritional management. TOOLS AND METHODS This is a descriptive observational study of adult patients admitted to the endocrinology service for additional care after a stay in intensive care during the period from April 17, 2020 to May 26, 2020. The assessment tool used was the Mini Nutritional Assessment (MNA). RESULTS Our study included 41 patients; the average age of the patients was 55 years, 51.2% had a severe or critical form of COVID-19, 75.6% stayed in intensive care, 12.2% had a loss of autonomy. The average BMI was 25.2 kg/m2 (17-42 kg/m2), 42.5% were overweight, 61% had weight loss, 26.2% had weight loss greater than 10%, 14.6% of our patients were undernourished, 65.9% were at risk of undernutrition, 19.5% had hypoalbuminemia, 17.1% had hypoprotidemia, 19.5% hypocalcemia, 34.1% anemia, 12.2% hypomagnesemia and 51.2% had a deficiency in vitamin D. A positive correlation was found between poor nutritional status and a longer stay in intensive care (>5 days) (p = 0.011) and lymphopenia (p = 0,02). CONCLUSION Despite a personalized diet, 14.6% of patients presented undernutrition. Particular attention should be paid to patients with a long stay in intensive care.

Methodological quality

Publication Type : Observational Study

Metadata